Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. (300501.SZ)
CNY 14.24
(1.28%)
CNY 14.24
(1.28%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 175.28 Million CNY | -7.65% |
| 2022 | 178.2 Million CNY | 9.18% |
| 2021 | 154.05 Million CNY | 1.74% |
| 2020 | 162.19 Million CNY | 41.7% |
| 2019 | 113.33 Million CNY | 9.95% |
| 2018 | 104.3 Million CNY | 16.36% |
| 2017 | 90.17 Million CNY | 9.17% |
| 2016 | 81.88 Million CNY | 9.14% |
| 2015 | 75.88 Million CNY | 10.84% |
| 2014 | 68.35 Million CNY | 8.9% |
| 2013 | 60.91 Million CNY | 30.85% |
| 2012 | 48.94 Million CNY | 80.32% |
| 2011 | 26.7 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 30.42 Million CNY | -46.71% |
| 2024 Q1 | 34.74 Million CNY | 93.39% |
| 2024 Q2 | 54.62 Million CNY | 15.65% |
| 2023 Q4 | 25.52 Million CNY | -55.32% |
| 2023 Q2 | 29.83 Million CNY | -19.44% |
| 2023 FY | - CNY | -7.65% |
| 2023 Q1 | 37.03 Million CNY | 10.29% |
| 2023 Q3 | 57.13 Million CNY | 91.5% |
| 2022 Q1 | 34.4 Million CNY | 7.95% |
| 2022 FY | - CNY | 9.18% |
| 2022 Q4 | 33.57 Million CNY | 2.58% |
| 2022 Q3 | 32.73 Million CNY | -8.65% |
| 2022 Q2 | 35.83 Million CNY | 4.14% |
| 2021 Q3 | 23.82 Million CNY | -26.05% |
| 2021 Q2 | 32.21 Million CNY | -23.58% |
| 2021 Q4 | 31.87 Million CNY | 33.8% |
| 2021 FY | - CNY | 1.74% |
| 2021 Q1 | 42.15 Million CNY | 17.9% |
| 2020 Q2 | 43.39 Million CNY | 145.51% |
| 2020 FY | - CNY | 41.7% |
| 2020 Q1 | 17.67 Million CNY | 14.16% |
| 2020 Q4 | 35.75 Million CNY | 9.82% |
| 2020 Q3 | 32.55 Million CNY | -24.98% |
| 2019 FY | - CNY | 9.95% |
| 2019 Q4 | 15.48 Million CNY | -37.67% |
| 2019 Q3 | 24.83 Million CNY | 8.83% |
| 2019 Q2 | 22.82 Million CNY | 16.51% |
| 2019 Q1 | 19.58 Million CNY | 5.03% |
| 2018 Q4 | 18.65 Million CNY | -6.95% |
| 2018 FY | - CNY | 16.36% |
| 2018 Q3 | 20.04 Million CNY | -21.26% |
| 2018 Q2 | 25.45 Million CNY | 35.93% |
| 2018 Q1 | 18.72 Million CNY | -33.2% |
| 2017 Q4 | 28.03 Million CNY | 96.65% |
| 2017 Q3 | 14.25 Million CNY | -47.29% |
| 2017 FY | - CNY | 9.17% |
| 2017 Q1 | 15.65 Million CNY | -31.69% |
| 2017 Q2 | 27.04 Million CNY | 72.72% |
| 2016 Q4 | 22.92 Million CNY | 51.23% |
| 2016 FY | - CNY | 9.14% |
| 2016 Q3 | 15.15 Million CNY | -29.35% |
| 2016 Q2 | 21.45 Million CNY | 40.22% |
| 2016 Q1 | 15.3 Million CNY | -31.82% |
| 2015 Q2 | 23.04 Million CNY | 63.68% |
| 2015 FY | - CNY | 10.84% |
| 2015 Q1 | 14.07 Million CNY | 0.0% |
| 2015 Q3 | 12.89 Million CNY | -44.03% |
| 2015 Q4 | 22.44 Million CNY | 74.03% |
| 2014 FY | - CNY | 8.9% |
| 2013 FY | - CNY | 30.85% |
| 2012 FY | - CNY | 80.32% |
| 2011 FY | - CNY | 0.0% |